QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
NYSE:HEXO

HEXO - HEXO Price Target & Analyst Ratings

$1.28
-0.05 (-3.76%)
(As of 03/28/2023 05:37 PM ET)
Add
Compare
Today's Range
$1.24
$1.32
50-Day Range
$1.22
$1.81
52-Week Range
$0.90
$9.58
Volume
232,790 shs
Average Volume
1.16 million shs
Market Capitalization
$55.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HEXO Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 6 Analyst Ratings

Consensus Analyst Price Target

N/A

TypeCurrent
3/28/22 to 3/28/23
1 Month Ago
2/26/22 to 2/26/23
3 Months Ago
12/28/21 to 12/28/22
1 Year Ago
3/28/21 to 3/28/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
3 Buy rating(s)
Hold
5 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price TargetN/A$12.60$10.01$10.01
Predicted UpsideN/A49.75% Upside35.67% Upside-59.11% Downside
Get HEXO Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter.

HEXO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HEXO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

HEXO Stock vs. The Competition

TypeHEXOMedical CompaniesS&P 500
Consensus Rating Score
1.83
2.64
2.47
Consensus RatingHoldBuyHold
Predicted Upside2,001.15% Upside22.46% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/21/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
W. Kirk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral
12/16/2022CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral
6/16/2022Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Zuanic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral
6/16/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
6/15/2022Atb Cap Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
F. Gomes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeSector Perform ➝ Underperform
6/15/2022Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
1/27/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Hold$14.98 ➝ $7.42+8.16%
6/16/2021Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHoldC$112.00 ➝ C$105.00
3/22/2021BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform
2/4/2021Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSell$47.60-57.12%
7/1/2020Bryan, Garnier & Co
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Sell
6/12/2020MKM Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
William Kirk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold$15.40+7.84%
6/11/2020Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold
3/31/2020Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform
3/31/2020Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform$14.00+26.58%
(Data available from 3/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












HEXO Price Target - Frequently Asked Questions

What is HEXO's consensus rating?

According to the issued ratings of 6 analysts in the last year, the consensus rating for HEXO stock is Hold based on the current 1 sell rating and 5 hold ratings for HEXOthe . Learn more on HEXO's analyst rating history.

Do Wall Street analysts like HEXO more than its competitors?

Analysts like HEXO less than other Medical companies. The consensus rating for HEXO is Hold while the average consensus rating for medical companies is Buy. Learn more on how HEXO compares to other companies.

What analysts cover HEXO?

HEXO has been rated by Roth Capital in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:HEXO) was last updated on 3/28/2023 by MarketBeat.com Staff